Biowa,
yes it is. I believe they are pricing on Monday. Since P.P.Morgan is the lead maybe they will get some of the halo effect from the Genentech offering. I can't think of a better place to get approval and establish proof of principal for a oxygen therapuedic than South Africa where the blood supply is seriously tainted.
From Hoovers.com
Biopure Corporation
indicates features for Hoover's Online Members only.
--------------------------------------------------------------------------------
11 Hurley St.
Cambridge, MA 02141
Phone: 617-234-6500
Fax: 617-234-6505
Web Site: biopure.com
IPO
INFORMATION
--------------------------------------------------------------------------------
Filing date: May 19, 1999
Expected IPO date: Week of July 26
Exchange: Nasdaq
Proposed ticker: BPUR
Proposed offer price:
$15.50 to $17.50
Shares offered (mil.): 4.5
Offering amount (mil.): $74.3
Post-offering shares (mil.): 22.771
Underwriters:
J.P. Morgan & Co.; Adams, Harkness & Hill, Inc.; Robert W. Baird & Co. Incorporated
KEY NUMBERS
--------------------------------------------------------------------------------
Fiscal Year-End: October
1998 Sales (mil.): $1.1
1998 Income (mil.): $(30.0)
Employees: 177
More Financials
KEY PEOPLE
--------------------------------------------------------------------------------
CEO: Carl W. Rausch
CFO: Daniel R. Davis
HR: Carolyn R. Fuchs
Biopure gives new meaning to blood work. The company makes an artificial blood product based on bovine red blood cells to deliver oxygen to patients with acute blood loss, anemia, or who have had a stroke or a heart attack. Its Hemopure, for humans, and Oxyglobin, for dogs (already approved for veterinary use), are made of purified and processed cow blood, have a two-year shelf life, do not require blood typing, and release more oxygen than a blood transfusion. The blood products also are less viscous than red blood cells, allowing them to flow more easily through partially blocked or constricted blood vessels. Chairman and CEO Carl Rausch owns about 44% of the company.
Additional Sources of Information
|
